Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MTOR Inhibitors”

622 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 622 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04948203
What this trial is testing

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

Who this might be right for
Pulmonary FibrosisCOVID-19 PneumoniaLong COVID
University of Chicago 60
Not applicableStudy completedNCT05198427
What this trial is testing

MTOR Inhibitors: the Lesions Induced by Papillomavirus for Transplant Patients.

Who this might be right for
Transplantation Organ
Hospices Civils de Lyon 45
Large-scale testing (Phase 3)Looking for participantsNCT05643872
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita

Who this might be right for
Pachyonychia Congenita
Palvella Therapeutics, Inc. 45
Very early researchUnknownNCT05532072
What this trial is testing

Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy.

Who this might be right for
Graves Ophthalmopathy
First Affiliated Hospital Xi'an Jiaotong University 140
Testing effectiveness (Phase 2)Study completedNCT00499486
What this trial is testing

Sirolimus in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 47
Early research (Phase 1)Study completedNCT00830466
What this trial is testing

Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.

Who this might be right for
Port Wine Stain
University of California, Irvine 22
Early research (Phase 1)Study completedNCT00060645
What this trial is testing

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Who this might be right for
TumorsLymphomaMultiple Myeloma
Merck Sharp & Dohme LLC 33
Not applicableStudy completedNCT03730428
What this trial is testing

Everolimus Related Pneumonitis in MBC

Who this might be right for
EverolimusPneumonitis
Fudan University 86
Early research (Phase 1)Study completedNCT01031901
What this trial is testing

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

Who this might be right for
Tuberous SclerosisNeurofibromatosesAngiofibroma+1 more
The University of Texas Health Science Center, Houston 52
Not applicableNot Yet RecruitingNCT07767877
What this trial is testing

Clinical Practice and Real-world Care of Patients Treated With mTOR, PI3K, and MEK Inhibitors for Extracranial Vascular Anomalies

Who this might be right for
Vascular Anomalies
Novartis Pharmaceuticals 200
Early research (Phase 1)Study completedNCT00375245
What this trial is testing

Rapamycin With Grapefruit Juice for Advanced Malignancies

Who this might be right for
TumorsNeoplasm Metastasis
University of Chicago 41
Early research (Phase 1)Study completedNCT00622258
What this trial is testing

A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Novartis Pharmaceuticals 13
Post-approval studies (Phase 4)Study completedNCT00044720
What this trial is testing

Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

Who this might be right for
Chronic Kidney FailureGraft vs Host DiseaseKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 484
Early research (Phase 1)Study completedNCT00796796
What this trial is testing

Temsirolimus and Radiation for Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Washington University School of Medicine 10
Early research (Phase 1)WithdrawnNCT04994561
What this trial is testing

VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements

Who this might be right for
Aging
Vitality in Aging Research Group, Inc.
Early research (Phase 1)Study completedNCT00635284
What this trial is testing

ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies

Who this might be right for
Solid Tumors
Celgene 27
Testing effectiveness (Phase 2)Study completedNCT01019434
What this trial is testing

Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 111
Post-approval studies (Phase 4)UnknownNCT03500367
What this trial is testing

Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis

Who this might be right for
Uterine Fibroids
Peking Union Medical College Hospital 25
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Study completedNCT00474929
What this trial is testing

Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 103
Next Page